EP News Bureau

Rankings were done on the basis of recommendations of a Core Committee set up by MHRD

Lupin’s biosimilar plans are reaching a crucial inflexion point, with recent positive global Phase III results of its etanercept…

The pigments can regulate a key enzyme in cancer cells

Promising anti-fungal and anti-inflammatory properties for vaginal candidiasis therapy

The French drugmaker warned in November that Dengvaxia, first approved in late 2015, could increase the risk of severe dengue in…

Safety data supported a lower 2 mg dose of the drug, baricitinib, but not a 4 mg dose, raising questions whether the higher dose…

The transaction was completed through its 70 per cent subsidiary, Kremoint Pharma

The growth will be driven by new therapies entering the market and a global aging society, which will lead to increasing numbers…

China currently appears to be in a much better position from a negotiation standpoint, as the Chinese biopharma industry does not…

Tabletting, one of the most essential processes in pharma manufacturing industry needs to undergo a metamorphosis to anticipate…